⌕
Stevanato Group · STVN · NYSE
Tenet — · insufficient data
Compare
$15.53−1.71%At close
$15.53−0.27 (−1.71%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.

Stevanato Group (STVN) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Business WireNov 16, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Stevanato Group to Participate in Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences i…

● Business WireNov 7, 2026 · 18:27 ET
STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $STVN--STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law.…

● GlobeNewsWireNov 4, 2026 · 17:05 ET
STVN INVESTOR ALERT: Investigation of Stevanato Group S.p.A. Announced by Holzer & Holzer, LLC

ATLANTA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Stevanato Group S.p.A. (“Stevanato” or the “Company”) (NYSE: STVN) complied with federal securities laws. On November 3, 2026, Stev…

● Business WireNov 4, 2026 · 13:20 ET
Lost Money on Stevanato Group S.p.A. Shares? The Law Offices of Frank R.

LOS ANGELES--(BUSINESS WIRE)--Stevanato Group S.p.A. ("Stevanato" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating p…

● Business WireNov 4, 2026 · 12:20 ET
Lost Money on Stevanato Group S.p.A. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.57% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Stevanato Group S.p.A. ("Stevanato" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced …

● Business WireNov 4, 2026 · 12:12 ET
Did You Lose Money on Stevanato Group S.p.A. Stock? The Law Offices of Howard G.

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Stevanato Group S.p.A. ("Stevanato" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that…

● GlobeNewsWireNov 4, 2026 · 08:38 ETCOMPANY'S OWN WORDS
Stevanato Group (STVN) Shareholder Investigation Following Stock Decline – Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of Stevanato Group (STVN) investors following the Company's stock price decline…

● MarketBeatNov 4, 2026 · 04:15 ET
Stevanato Group Q3 Earnings Call Highlights

Stevanato Group NYSE: STVN reported third-quarter 2026 revenue growth of 8% to €326.1 million, supported by continued expansion in its biopharmaceutical and diagnostic solutions business despite weaker demand tied to GLP…

● PRNewsWireNov 3, 2026 · 17:38 ETCOMPANY'S OWN WORDS
Stevanato Group S.p.A. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Stevanato Group S.p.A.

STVN shares fell on November 3, 2026, as the market reacted to a lower GLP-1 revenue outlook in Stevanato Group's pre-market third-quarter results, the issue previews had flagged as the quarter's key test. SueWallSt noti…

● Seeking AlphaNov 3, 2026 · 16:56 ET
Stevanato Group S.p.A. (STVN) Q3 2026 Earnings Call Transcript

Stevanato Group S.p.A. ( STVN ) Q3 2026 Earnings Call November 3, 2026 8:30 AM EST Company Participants Lisa Miles - Chief Communications & Investor Relations Officer Franco Stevanato - CEO & Executive Chairman Marco Dal…

● Zacks Investment ResearchNov 3, 2026 · 09:00 ET
Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue Estimates

Stevanato Group (STVN) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.16 per share a year ago.…

● Business WireNov 3, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences i…

● Seeking AlphaOct 27, 2026 · 10:35 ET
Conestoga Small Cap Composite Q3 2026 Portfolio Activity

The Conestoga Small Cap Composite returned -11.22% net of fees in 3Q26, trailing the -9.39% return for the Russell 2000 Growth Index. Small Cap Composite top 5 leaders include Repligen, Merit Medical, Stevanato Group, De…

● Business WireOct 27, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) (the “Company”), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and…

● Seeking AlphaOct 27, 2026 · 05:35 ET
Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update

The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exe…

● Business WireOct 20, 2026 · 16:30 ET
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences i…

● Seeking AlphaSep 15, 2026 · 17:01 ET
Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript…

● Business WireSep 8, 2026 · 16:05 ET
Stevanato Group to Participate in Two Upcoming Investor Conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences i…

● GuruFocusSep 1, 2026 · 20:00 ET
A Look at Stevanato Group SpA (STVN) After 3.4% Decline -- GF Value $25.98 vs Price $20.71

On September 01, 2026, Stevanato Group SpA (STVN) shares fell 3.4% to a current price of $20.71, trading within a 52-week range of $12.89 to $28.00. This recent…

● Seeking AlphaAug 29, 2026 · 08:11 ET
Stevanato Group: Alina Validates The Container-To-Device Flywheel

Stevanato Group is transforming from a pharmaceutical glass supplier into an integrated drug containment and delivery platform, validated by commercial adoption of its Alina injector. High-value solutions now drive 45% o…

● GuruFocusAug 28, 2026 · 20:08 ET
Stevanato Group SpA (STVN) Shares Fall 5.7% -- What GF Score of 87 Tells Investors

On August 28, 2026, Stevanato Group SpA (STVN) shares fell 5.7%, closing at $21.03. The stock has experienced a volatile year, with a 52-week range of $12.89 to…

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

Article counts from the last market-wide feed page, across every symbol we track and not just STVN · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.